See more : Korea Industrial Co., Ltd. (002140.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Harvest Health & Recreation Inc. (HRVSF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Harvest Health & Recreation Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- President Bakery Public Company Limited (PB.BK) Income Statement Analysis – Financial Results
- Godfrey Phillips India Limited (GODFRYPHLP.NS) Income Statement Analysis – Financial Results
- Chongyi Zhangyuan Tungsten Co., Ltd. (002378.SZ) Income Statement Analysis – Financial Results
- Southern BancShares (N.C.), Inc. PFD CL C (SBNCN) Income Statement Analysis – Financial Results
- Sunrise Efficient Marketing Li (SEML.BO) Income Statement Analysis – Financial Results
Harvest Health & Recreation Inc. (HRVSF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: http://www.harvesthoc.com
About Harvest Health & Recreation Inc.
Harvest Health and Recreation, Inc., together with its subsidiaries, cultivates, processes, sells, and retails inhalable, ingestible, and topical cannabis products in the United States. The company offers cannabis oil products; inhalables, including flower, dabbable concentrates, pre-filled vaporizer pens, and cartridges; and capsules, tinctures, and cannabis product edibles, including chocolates, gummies, mints, fruit chews, and dissolvable mouth strips under the Avenue, CBX SCIENCES, EVOLAB, ALCHEMY, CHROMA, CO2LORS, GOODSUN, MODERN FLOWER, and ROLL ONE brand names. It also operates retail dispensaries that sell proprietary and third-party cannabis products to patients and customers; and provides support services and financing to a Utah licensed medical cannabis cultivator. Harvest Health and Recreation, Inc. was founded in 2011 and is headquartered in Tempe, Arizona.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 231.46M | 116.78M | 77.79K | 200.29K | 284.45K | 482.02K | 675.22K | 368.83K | 292.64K | 233.88K | 180.62K | 147.97K | 24.10K |
| Cost of Revenue | 129.87M | 73.21M | 15.89K | 56.47K | 31.73K | 94.81K | 160.79K | 51.74K | 269.58K | 478.39K | 372.72K | 1.23M | 14.92K |
| Gross Profit | 101.59M | 43.57M | 61.91K | 143.82K | 252.72K | 387.20K | 514.43K | 317.09K | 23.05K | -244.51K | -192.10K | -1.08M | 9.18K |
| Gross Profit Ratio | 43.89% | 37.31% | 79.58% | 71.81% | 88.84% | 80.33% | 76.19% | 85.97% | 7.88% | -104.55% | -106.36% | -728.50% | 38.10% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 122.10M | 115.86M | 83.35K | 65.96K | 78.32K | 129.18K | 251.07K | 246.79K | 446.60K | 505.30K | 498.98K | 498.25K | 0.00 |
| Selling & Marketing | 4.96M | 8.94M | 0.00 | 0.00 | 0.00 | 0.00 | 1.40K | 0.00 | 1.26K | 0.00 | 10.93K | 0.00 | 0.00 |
| SG&A | 127.06M | 124.80M | 83.35K | 65.96K | 78.32K | 129.18K | 252.46K | 246.79K | 447.86K | 505.30K | 509.91K | 498.25K | 0.00 |
| Other Expenses | 7.92M | 10.30M | 93.75K | 126.55K | 300.84K | 408.79K | 308.00K | 180.03K | 55.80K | 0.00 | 0.00 | 0.00 | 1.46M |
| Operating Expenses | 134.98M | 135.10M | 177.10K | 192.51K | 379.15K | 537.97K | 560.47K | 426.82K | 503.65K | 505.30K | 509.91K | 498.25K | 1.46M |
| Cost & Expenses | 264.85M | 208.30M | 192.98K | 248.98K | 410.89K | 632.79K | 721.26K | 478.56K | 773.24K | 983.69K | 882.64K | 1.72M | 1.48M |
| Interest Income | 444.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 60.03 | 615.56 | 568.96 | 1.21K | 1.98K | 9.68K | 1.53K |
| Interest Expense | 39.06M | 16.24M | 4.78K | 5.50K | 3.34K | 5.27K | 6.99K | 10.34K | 32.61K | 27.68K | 16.64K | 2.28K | 0.00 |
| Depreciation & Amortization | 16.67M | 12.69M | 2.93K | 5.22K | 3.29K | 13.51K | 24.44K | 6.09K | 55.80K | 200.11K | 165.86K | 991.47K | 651.57K |
| EBITDA | -259.00K | -140.80M | -347.62K | -43.47K | -109.40K | -110.67K | -219.74K | -125.25K | -25.86K | -645.52K | -1.56M | -575.04K | -801.24K |
| EBITDA Ratio | -0.11% | -120.57% | -446.85% | -21.71% | -38.46% | -22.96% | -32.54% | -33.96% | -8.84% | -276.01% | -866.36% | -388.63% | -3,324.16% |
| Operating Income | -33.39M | -91.52M | -115.19K | -48.69K | -126.44K | -150.77K | -46.04K | -109.73K | -480.60K | -749.81K | -702.02K | -1.58M | -1.45M |
| Operating Income Ratio | -14.43% | -78.37% | -148.07% | -24.31% | -44.45% | -31.28% | -6.82% | -29.75% | -164.23% | -320.60% | -388.67% | -1,065.22% | -6,033.34% |
| Total Other Income/Expenses | -21.26M | -80.29M | -240.14K | -5.50K | 10.40K | 21.32K | -205.13K | -31.96K | 366.34K | -97.03K | -933.72K | 0.00 | 0.00 |
| Income Before Tax | -54.65M | -171.81M | -355.33K | -54.19K | -116.04K | -129.45K | -251.17K | -141.69K | -114.26K | -846.84K | -1.64M | 0.00 | 0.00 |
| Income Before Tax Ratio | -23.61% | -147.12% | -456.76% | -27.06% | -40.79% | -26.86% | -37.20% | -38.42% | -39.05% | -362.08% | -905.63% | 0.00% | 0.00% |
| Income Tax Expense | 3.65M | 3.76M | -235.36K | 0.00 | 13.75K | 26.59K | -198.14K | -21.61K | 398.95K | -69.35K | -917.09K | 2.28K | 0.00 |
| Net Income | -59.63M | -173.49M | -355.33K | -54.19K | -116.04K | -129.45K | -251.17K | -141.69K | -114.26K | -873.31K | -1.75M | -1.57M | -1.45M |
| Net Income Ratio | -25.76% | -148.56% | -456.76% | -27.06% | -40.79% | -26.86% | -37.20% | -38.42% | -39.05% | -373.40% | -967.40% | -1,060.22% | -6,027.36% |
| EPS | -0.17 | -0.61 | -0.08 | -0.01 | -0.03 | -0.03 | -0.06 | -0.04 | -0.04 | -0.42 | -1.23 | -1.53 | -3.86 |
| EPS Diluted | -0.17 | -0.61 | -0.08 | -0.01 | -0.03 | -0.03 | -0.06 | -0.04 | -0.04 | -0.42 | -1.23 | -1.53 | -3.86 |
| Weighted Avg Shares Out | 354.76M | 286.63M | 4.59M | 4.00M | 4.00M | 4.00M | 3.95M | 3.22M | 2.79M | 2.09M | 1.43M | 1.03M | 376.52K |
| Weighted Avg Shares Out (Dil) | 354.76M | 286.63M | 4.59M | 4.00M | 4.00M | 4.00M | 3.95M | 3.22M | 2.79M | 2.09M | 1.43M | 1.03M | 376.52K |
Top Reopening Penny Stocks to Watch in May 2021
3 Growth Stocks That'll Make You Richer in May (and Beyond)
Best Marijuana Stocks To Buy In May 2021? 3 With Potential This Week
5 Small-Cap Stocks With 60% to 140% Upside, According to Wall Street
Best Marijuana Penny Stocks For May 2021
Looking For Marijuana Stocks To Buy Right Now? 2 Cannabis Stocks To Watch During This Downtrend
Harvest Health: Arizona Boost Improves Story
5 Pot Stocks With 44% to 70% Upside, According to Wall Street
Verano: Latest Addition To The Top U.S. Cannabis MSOs
3 Top Marijuana Stocks to Buy Right Now
Source: https://incomestatements.info
Category: Stock Reports